ArticleFrontiers in endocrinology2025

Development of a risk prediction model for gastrointestinal adverse events associated with semaglutide administration in patients with type 2 diabetes mellitus.

Deyong Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.